Dashboard
Manage Tickers

ABVC ABVC BIOPHARMA, INC.

Nasdaq abvcpharma.com


$ 3.00 $ 0.21 (7.5 %)    

Monday, 03-Nov-2025 14:08:27 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 632.20 $ -3.02 (-0.48 %)
DIA $ 473.52 $ -2.61 (-0.55 %)
SPY $ 683.50 $ -2.15 (-0.31 %)
TLT $ 89.65 $ 0.00 (0 %)
GLD $ 368.97 $ 0.17 (0.04 %)
$ 2.8
$ 2.80
$ 2.94 x 100
$ 3.00 x 1,103
$ 2.87 - $ 3.02
$ 0.40 - $ 5.48
37,048
na
65.12M
$ 0.98
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-31-2025 09-30-2025 10-Q
2 08-13-2025 06-30-2025 10-Q
3 04-30-2025 03-31-2025 10-Q
4 04-15-2025 12-31-2024 10-K
5 11-14-2024 09-30-2024 10-Q
6 08-14-2024 06-30-2024 10-Q
7 05-17-2024 03-31-2024 10-Q
8 03-13-2024 12-31-2023 10-K
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-31-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-11-2021 06-30-2021 10-Q
18 05-10-2021 03-31-2021 10-Q
19 03-16-2021 12-31-2020 10-K
20 11-17-2020 09-30-2020 10-Q
21 08-14-2020 06-30-2020 10-Q
22 06-30-2020 03-31-2020 10-Q
23 05-15-2020 12-31-2019 10-K
24 11-18-2019 09-30-2019 10-Q
25 08-09-2019 06-30-2019 10-Q
26 05-28-2019 03-31-2019 10-Q
27 04-15-2019 12-31-2018 10-K
28 11-14-2018 09-30-2018 10-Q
29 08-20-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 01-16-2018 09-30-2017 10-K
32 08-21-2017 06-30-2017 10-Q
33 05-22-2017 03-31-2017 10-Q
34 02-21-2017 12-31-2016 10-Q
35 01-12-2017 09-30-2016 10-K
36 08-15-2016 06-30-2016 10-Q
37 05-16-2016 03-31-2016 10-Q
38 02-23-2016 12-31-2015 10-Q
39 11-27-2015 09-30-2015 10-K
40 08-19-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

abvc-biopharma-q3-eps-005-down-from-003-yoy-sales-795950k-up-from-389276k-yoy
ABVC BioPharma Q3 EPS $(0.05) Down From $(...
11/03/2025 14:16:35

ABVC BioPharma (NASDAQ:ABVC) reported quarterly losses of $(0.05) per share. This is a 66.67 percent decrease over losses of $(...

abvc-biopharma-q2-eps-013-down-from-009-yoy
ABVC BioPharma Q2 EPS $(0.13) Down From $(...
08/13/2025 21:40:39

ABVC BioPharma (NASDAQ:ABVC) reported quarterly losses of $(0.13) per share. This is a 44.44 percent decrease over losses of $(...

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
06/06/2025 21:05:52

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
05/21/2025 17:06:44

abvc-biopharma-secures-japanese-patent-for-its-natural-mdd-treatment-candidate-abv-1504
'ABVC BioPharma Secures Japanese Patent Fo...
05/09/2025 15:05:09

ABVC BioPharma, Inc. (NASDAQ:ABVC), a clinical-stage biopharmaceutical company developing botanical-based therapies for central...

abvc-biopharma-determined-that-it-has-a-material-weakness-in-its-internal-controls-over-financial-reporting-concluded-that-financial-statements-for-fy-ended-dec-31-2023-should-no-longer-be-relied-upon-due-to-errors-in-financial-statements
ABVC BioPharma Determined That It Has A Ma...
04/15/2025 20:43:26

- SEC Filing

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/08/2025 21:05:50

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
03/31/2025 17:05:39

abvc-biopharmas-leeds-chow-resigns-as-cfo-ceo-uttam-patil-to-serve-as-interim-cfo
Abvc Biopharma's Leeds Chow Resigns As CFO...
03/07/2025 21:26:17

- SEC Filing

abvc-biopharma-seeks-to-revolutionize-mental-health-treatment-with-a-safe-prozac-alternative-boasting-a-madrs-score-reduction-of--1321-from-baseline-over-6-weeks-with-a-placebo-subtracted-difference-of--41
ABVC BioPharma Seeks To Revolutionize Ment...
12/19/2024 13:34:09

ABVC BioPharma, Inc. (NASDAQ:ABVC), a clinical-stage biopharmaceutical company focused on innovative treatments in ophthalmolog...

abvc-biopharma-reveals-receipt-of-200k-cash-payment-from-oncox-biopharma-as-part-of-its-strategic-licensing-agreement-for-certain-oncology-related-products
ABVC BioPharma Reveals Receipt Of $200K Ca...
12/11/2024 11:32:44

This payment marks the first installment of $5 million in potential licensing fees from OncoX.With this payment, the total accu...

abvc-biopharma-q3-eps-002-up-from-082-yoy-sales-38928k-up-from-1588k-yoy
ABVC BioPharma Q3 EPS $(0.02) Up From $(0....
11/14/2024 14:01:53

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
10/29/2024 20:31:07

abvc-biopharma-receives-50000-in-incremental-licensing-fees
ABVC BioPharma Receives $50,000 In Increme...
10/22/2024 12:51:51

With this payment, ABVC has received a total of $346,000 in licensing fees from its strategic partners, supporting our partner&...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
10/16/2024 12:10:05

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
10/15/2024 20:30:52

abvc-biopharma-got-written-notification-from-nasdaq-indicating-co-regained-compliance-with-listing-rules-5635a1-and-5635a2
ABVC Biopharma Got Written Notification Fr...
09/10/2024 20:15:15

- SEC Filing

abvc-biopharma-q2-eps-009-up-from-068-yoy-sales-11714k-up-from-611k-yoy
ABVC BioPharma Q2 EPS $(0.09) Up From $(0....
08/15/2024 11:08:55

abvc-biopharma--biolite-entered-into-definitive-agreement-with-oncox-biopharma-to-collaborate-on-combination-therapy-abvc--unit-are-eligible-to-receive-aggregate-license-fee-of-125m-in-form-of-cash-or-shares-of-oncox-securities-under-terms-of-deal-abvc-grants-oncox-exclusive-rights-for-one-of-abvcs-4-products-in-its-oncology-pipeline
ABVC Biopharma & Biolite Entered Into Defi...
05/24/2024 12:17:39

- SEC Filing 

abvc-biopharma-collaboration-between-abvc-and-oncox-biopharma-abvc-expecting-aggregate-income-of-1375m-and-royalties-of-up-to-1250m-grants-oncox-exclusive-rights-for-one-of-abvcs-four-products-in-its-oncology-pipeline-to-develop-manufacture-commercialize-blex-404
ABVC Biopharma Collaboration Between ABVC ...
05/09/2024 13:41:48

https://www.sec.gov/ix?doc=/Archives/edgar/data/1173313/000121390024041053/ea0205569-8k_abvcbio.htm

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION